Ideal for individuals seeking injury recovery support, gut health optimisation, and overall regenerative wellness
Antiretroviral drugs (ritonavir, a known CYP2D6 inhibitor) and MAO inhibitors have been reported to be the main cause of life threatening interactions with MDMA (Henry and Hill, 1998
Regular monitoring of blood glucose, liver function, lipid profiles, and cardiovascular parameters is advisable, and harm reduction services are available for confidential support
Additionally, concurrent use with other GLP-1 receptor agonists is not recommended due to duplicative therapy
"The risk of developing the condition is more than four times higher in people with obesity," Bliddal added in a Novo Nordisk news release
One of the most informative articles was published in 2016 in the Journal: Obesity reviews